missing translation for 'onlineSavingsMsg'
Learn More

Cyclin D1 Rabbit anti-Human, Clone: CCND1/3370R, Novus Biologicals™

Rabbit Monoclonal Antibody

2685.00 NOK

Specifications

Antigen Cyclin D1
Clone CCND1/3370R
Concentration 0.2 mg/ml
Dilution Immunohistochemistry-Paraffin 1-2 ug/ml
Applications Immunohistochemistry (Paraffin)
View More Specs

Products 1
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
18329556
View Documents
Bio-Techne
NBP3-07209-20UG
20 μg
2685.00 NOK
20µg
Please to purchase this item. Need a web account? Register with us today!
Description

Description

Cyclin D1 Monoclonal specifically detects Cyclin D1 in Human samples. It is validated for Immunohistochemistry-Paraffin.
Specifications

Specifications

Cyclin D1
0.2 mg/ml
Immunohistochemistry (Paraffin)
Unconjugated
Rabbit
Cancer, Cell Cycle and Replication, Core ESC Like Genes, mTOR Pathway, Stem Cell Markers, Wnt Signaling Pathway
10 mM PBS with 0.05% BSA
595
IgG
Protein A or G purified
CCND1/3370R
Immunohistochemistry-Paraffin 1-2 ug/ml
Monoclonal
Purified
RUO
Human
B-cell lymphoma 1 protein, BCL-1, BCL-1 oncogene, BCL1D11S287E, cyclin D1, cyclin D1 (PRAD1: parathyroid adenomatosis 1), G1/S-specific cyclin D1, G1/S-specific cyclin-D1, PRAD1 oncogene, PRAD1B-cell CLL/lymphoma 1, U21B31
A synthetic peptide corresponding to residues within aa 270-295 of Cyclin D1
Primary
Store at 4°C.
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.